Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides technologies and products used in the manufacturing of biologic drugs. Under deal ...

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, ...

On the heels of a move to reduce its viral vector manufacturing workforce, Thermo Fisher is beefing ... The department is focused on offering upstream cell culture, downstream purification ...

Today, Thermo Fisher has a leading portfolio of offerings in cell culture media and single-use technologies. Solventum’s innovative filtration portfolio broadens Thermo Fisher’s capabilities ...

Thermo Fisher Scientific Inc. (Waltham, Mass.) announced that the company has entered into a definitive agreement with Solventum  to acquire Solventum’s ...